Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 49,299 shares at $65.08 ($3.2M) on 2026-05-26, disclosed to the SEC on 2026-05-28.
Scheduled sale ($3.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.08 | 24,282 | $1.6M | 49.2% |
| 2 | $65.24 | 23,752 | $1.5M | 48.2% |
| 3 | $66.28 | 1,265 | $84K | 2.6% |
| Total | $65.19 avg | 49,299 | $3.2M | 100% |
| Filing → |
| TWST | SELL | 2026-09-25 | $923K | — | Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |